NSE JUBLINGREA · BSE 543271 · Chemical Manufacturing · NIFTY 500

Jubilant Ingrevia Share Price

Market closed · updated 25 Sep, 4:41 PM IST
₹634.85 ▼ −₹4.54 · 0.71% NSE · as of 24 Sep 2026, 8:53 AM · BSE ₹635.55
Today's range
₹632.60Low₹649.50High
52-week range
₹535.30Low · 9 Mar 2026₹794.95High · 22 Jul 2026

Jubilant Ingrevia Overview

Where the price stands, how it has moved and how it sits against its averages.

Jubilant Ingrevia shares last traded at ₹634.85 on the NSE, down 0.71% on the day. That is 20.1% below the 52-week high of ₹794.95 and 18.6% above the 52-week low of ₹535.30. The stock trades at 31.14× earnings, above the sector average of 20.26. Its market value is ₹10,094 Cr.

Price returns

1 Day▼ −0.71%
5 Days▲ +1.42%
This month▼ −5.03%
3 Months▲ +1.43%
6 Months▲ +9.78%
This year▼ −8.88%
1 Year▼ −4.61%

Against the market: 1 Month ▼ −6.29% · 3 Months ▲ +4.36% · 6 Months ▲ +10.43% · This year ▲ +3.77% · 1 Year ▲ +4.66%

Shading grows with the size of the move. Prices refresh every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next update from Mon 28 Sep, 9:15 AM.

Moving averages — price is above 1 of 6

  1. 50-day average₹708.07 ▼ price 10.3% below
  2. 100-day average₹693.04 ▼ price 8.4% below
  3. 300-day average₹670.64 ▼ price 5.3% below
  4. 20-day average₹666.30 ▼ price 4.7% below
  5. 10-day average₹643.85 ▼ price 1.4% below
  6. Today's price₹634.85
  7. 5-day average₹626.99 ▲ price 1.3% above

Averages above today's price sit higher on the ladder. Price above most of its averages is usually read as an upward trend.

Jubilant Ingrevia Financial Results

Revenue and net profit in ₹ crore, with the full statements underneath.

Revenue₹ crore
4,949
4,388
Net profit₹ crore · losses below zero
477
278

Year by year

Fiscal yearRevenueGrowthNet profitNet marginEPSDividend
FY 2026 ₹4,388 Cr ▲ +5.0% ₹278 Cr 6.3% ₹17.51 ₹5.00
FY 2025 ₹4,178 Cr ▲ +1.0% ₹251 Cr 6.0% ₹15.84 ₹5.00
FY 2024 ₹4,136 Cr ▼ −13.3% ₹183 Cr 4.4% ₹11.55 ₹5.00
FY 2023 ₹4,773 Cr ▼ −3.6% ₹308 Cr 6.4% ₹19.34 ₹5.00
FY 2022 ₹4,949 Cr ▲ +623.5% ₹477 Cr 9.6% ₹29.97 ₹5.00
FY 2021 ₹684 Cr — ₹54 Cr 7.9% ₹3.41 ₹0.35

Balance sheet — FY26

Owes (liabilities)Shareholders' equity
43%
57%
  • Total assets₹5,484 Cr
  • Total liabilities₹2,358 Cr
  • Shareholders' equity₹3,126 Cr
  • Total debt₹792 Cr
  • Cash & investments₹196 Cr
  • Current ratio1.29×
  • Revenue growth, 5 yr45.02% a year
  • EPS growth, 5 yr38.68% a year
  • Operating margin (TTM)9.14%
  • Net margin (TTM)6.64%

Cash flow — FY26

Operating activities
▲ ₹524 Cr
Investing activities
▼ −₹276 Cr
Financing activities
▼ −₹155 Cr
Free cash flow
▲ ₹225 Cr
Net change in cash
▲ ₹119 Cr

Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.

Full financial statements, FY21–FY26
₹ croreFY21FY22FY23FY24FY25FY26
Total revenue684.134,949.364,772.694,135.804,177.624,388.07
Cost of revenue453.103,426.713,405.502,771.132,687.492,827.65
Gross profit231.031,522.651,367.191,364.671,490.121,560.41
Operating expenses598.684,215.274,328.593,841.803,809.553,987.94
Operating income85.46734.09444.10294.00368.06400.13
Depreciation22.06123.38122.18136.17157.63175.48
Profit before tax77.39708.94436.71267.61343.62369.74
Tax23.03232.23129.2284.7292.4491.84
Net profit54.36476.71307.50182.89251.18277.90
EPS (₹)3.4129.9719.3411.5515.8417.51
Dividend per share (₹)0.355.005.005.005.005.00

What Analysts Say

6 analysts

Recommendations from 6 analysts who cover Jubilant Ingrevia.

Strong Buy average rating 1.50 on a 1–5 scale

▲ 5 bullish (83.3%) · 1 hold (16.7%) · ▼ 0 bearish (0.0%)

Votes

Strong Buy
4 (67%)
Buy
1 (17%)
Hold
1 (17%)
Sell
0 (0%)
Strong Sell
0 (0%)

How the votes changed

Rating3M ago2M ago1M ago1W agoNow3-month change
Strong Buy44444 —
Buy11111 —
Hold01111 ▲ +1
Sell10000 ▼ −1
Strong Sell00000 —

Analyst ratings are opinions, not a guarantee of returns.

Jubilant Ingrevia vs Peers

Side by side with other chemical manufacturing companies. The small bars compare each column.

CompanyPriceChangeMarket capP/EP/BROE (5 yr)Net marginDiv. yieldRating
Jubilant Ingrevia ₹634.85 ▼ −0.71% ₹10,094 Cr 31.14 3.23 11.26% 6.64% 0.78% This stock
Asian Paints ₹2,400.00 ▼ −2.17% ₹2,30,207 Cr 58.09 12.06 24.22% 12.35% 1.02% Bearish
Solar Industries India ₹19,619.95 ▼ −0.51% ₹1,77,541 Cr 99.61 26.62 30.43% 17.65% 0.06% Neutral
Pidilite Industries ₹1,537.15 ▼ −3.08% ₹1,56,463 Cr 64.76 14.71 21.84% 16.92% 0.73% Moderately Bearish
SRF ₹2,527.15 ▼ −0.51% ₹74,911 Cr 44.57 6.07 15.85% 11.62% 0.31% Bearish
Linde India ₹6,179.65 ▼ −1.73% ₹52,703 Cr 110.53 14.22 — 21.69% 0.06% Bearish

Rating = the data provider's overall technical view of each peer. Company names link to their own pages.

Shareholding Pattern

Who owns Jubilant Ingrevia shares, quarter by quarter (latest on top).

PromoterFIIMFOther
Jun '26
45.2%
22.4%
25.9%
Mar '26
Dec '25
Sep '25
HolderSep '25Dec '25Mar '26Jun '26Change
Promoter45.22%45.22%45.22%45.22% 0.00 pts
FII5.96%6.15%6.49%6.49% 0.00 pts
MF20.41%21.46%22.21%22.39% ▲ +0.18 pts
Other28.41%27.17%26.08%25.90% ▼ −0.18 pts

Jubilant Ingrevia Key Metrics

Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.

Jubilant IngreviaBenchmarkComfortable → stretched

Valuation Is the price reasonable?

P/E (TTM)Price ÷ yearly earnings per share
31.14
▲ 54% above the sector average of 20.26
P/E, 12-month rangeLow 15.01 · high 69.96
29%
Today's P/E sits 29% of the way from its low to its high
P/BPrice ÷ book value per share
3.23
P/SPrice ÷ sales per share
2.17
P/CFPrice ÷ cash flow per share
20.45

Profitability Of every ₹100 of sales, how much is kept?

Gross marginKept after the cost of goods
38.49%
▲ above its 5-yr average of 32.58%
Operating marginKept after running costs
9.14%
▼ below its 5-yr average of 9.99%
Pre-tax marginKept before tax
8.83%
▼ below its 5-yr average of 9.48%
Net marginKept as profit
6.64%
▼ below its 5-yr average of 6.67%

Returns & efficiency How well does it use its money?

Return on equityProfit on shareholders' money
9.18%
▼ below its 5-yr average of 11.26%
Return on assetsProfit on everything it owns
5.29%
▼ below its 5-yr average of 6.72%
Return on investmentProfit on long-term capital
7.39%
▼ below its 5-yr average of 9.30%

Growth Is the business getting bigger?

Revenue — last 12 months
+11.0%
▲ growing
Revenue — 3 yr, a year
−2.8%
▼ shrinking
Revenue — 5 yr, a year
+45.0%
▲ growing (off the scale)
EPS — last 12 months
+11.0%
▲ growing
EPS — 3 yr, a year
−3.3%
▼ shrinking
EPS — 5 yr, a year
+38.7%
▲ growing (off the scale)
Dividend — 3 yr, a year
0.0%
▲ growing
Book value — 5 yr, a year
+10.4%
▲ growing

Financial strength Can it pay its bills and debts?

Debt to equityBorrowings for every ₹1 of shareholders' money
0.25×
✓ Low debt
Current ratioShort-term assets for every ₹1 due within a year
1.29×
• Adequate
Quick ratioLike the current ratio, without inventory
0.72×
• Adequate
Interest coverOperating profit ÷ interest to pay
6.11×
✓ Strong
Payout ratioShare of profit paid as dividend
28.66%
• Keeps most

Per share What each share stands for

EPS (TTM)
₹19.42
Book value
₹198.24
Cash flow
₹31.13
Dividend
₹5.00
Revenue
₹292.86

The share price is 3.20× the book value behind each share.

Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.

All 110 metrics from the data provider

Valuation

P/E excluding extraordinary items, most recent fiscal year36.61
Current Dividend Yield - Common Stock Primary Issue, LTM0.78
Price to Book - most recent fiscal year3.23
P/E Basic excluding extraordinary items - TTM31.14
P/E including extraordinary items - TTM33.01
P/E excluding extraordinary items low, trailing 12 months15.01
Price to Tangible Book - most fiscal year3.27
Dividend Yield - 5 Year Average1.02
Price to sales - most recent fiscal year2.30
Dividend Yield - indicated annual dividend divided by closing price0.78
Price to Cash Flow per share - trailing 12 month20.45
Price to Free Cash Flow per Share - most recent fiscal year69.37
P/E Normalized, most recent fiscal year35.27
P/E excluding extraordinary items high, trailing 12 months69.96
P/E excluding extraordinary items, most recent fiscal year quarter33.01
Price to sales - trailing 12 month2.17
Net Debt, LFY5,962.74

Per share

Dividend Per Share - 5 year average5.00
Cash Flow per share - trailing 12 month31.13
Cash Flow per share - most recent fiscal year28.56
EPS including extraordinary items - trailing 12 month19.42
EPS including extraordinary items - most recent fiscal year17.51
EBITD per share - trailing 12 month39.27
Revenue/share - trailing 12 month292.86
EPS excluding extraordinary items - trailing 12 month19.42
EPS Basic excluding extraordinary items - most recent fiscal year17.58
EPS Basic excluding extraordinary items - trailing 12 month19.53
Book value per share - most recent fiscal year198.22
Dividend per share - most recent fiscal year5.00
Revenue/share - most recent fiscal year276.46
EPS Normalized - most recent fiscal year18.17
Book value (tangible) per share - most recent fiscal year196.00
Dividends per share - trailing 12 month5.00
EPS excluding extraordinary items - most recent fiscal year17.51
Cash per share - most recent fiscal year12.40

Margins

Operating margin - trailing 12 month9.14
Gross Margin - 5 year average32.58
Operating margin - 1st historical fiscal year9.12
Operating Margin - 5 year average9.99
Net Profit Margin % - 1st historical fiscal year6.33
Gross Margin - 1st historical fiscal year35.56
Net Profit Margin % - trailing 12 month6.64
Net Profit Margin - 5 year average6.67
Pretax Margin - 5 year average9.48
Pretax margin - 1st historical fiscal year8.43
Pretax margin - trailing 12 month8.83
Free Operating Cash Flow/Revenue, 5 Year Average0.31
Gross Margin - trailing 12 month38.49

Growth

EPS Change %, TTM over TTM10.95
Revenue growth rate, 5 year45.02
EPS growth rate, 5 year38.68
Revenue Change % - most recent quarter 1 year ago25.27
Growth rate% - dividend, 3 year0.00
Growth rate% - EPS, 3 year−3.26
Revenue/share (5 yr growth)45.12
Free Operating Cash Flow, 5 Year CAGR11.45
Tangible Book Value, Total Equity, 5 Year CAGR10.11
Capital Spending growth rate, 5 year61.15
Revenue Change %, TTM over TTM10.96
Growth rate% - Revenue, 3 year−2.76
Book value per share growth rate, 5 year10.43
EPS Change % - most recent quarter 1 year ago40.63
Net Profit Margin growth rate, 5 year−4.44
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR37.34
Total Debt, 5 Year CAGR7.34

Financial strength

Net Interest coverage - most recent fiscal year6.11
Free Cash Flow - most recent fiscal year1,457.32
LT debt/equity - most recent fiscal year0.11
Quick ratio - most recent fiscal year0.72
Payout ratio - trailing 12 month12.78
Current ratio - most recent fiscal year1.29
Current EV/Free Cash Flow, LFY143.16
Total debt/total equity - most recent fiscal year0.25
Net Interest coverage - trailing 12 month8.11
Payout ratio - most recent fiscal year28.66

Returns & efficiency

Return on average equity - 5 year average11.26
Net Income/employee - trailing 12 month14,04,090.00
Revenue/employee - most recent fiscal year2,02,35,490.00
Return on investment - most recent fiscal year7.39
Return on average assets - most recent fiscal year5.29
Receivables turnover - most recent fiscal year6.32
Inventory turnover - most recent fiscal year3.01
Revenue/employee - trailing 12 month2,11,57,350.00
Return on average assets - 5 year average6.72
Net Income/employee - most recent fiscal year12,81,526.00
Asset turnover - most recent fiscal year0.83
Return on average equity - most recent fiscal year9.18
Return on investment - 5 year average9.30

Price & volume

Market Cap10,265.68
52 week Low Date9 Mar 2026
Price - 1 Day % Change3.78
Relative (S&P500) price percent change - 13 week4.36
Avg trading volume last 10 days0.32
Price - 13 week price percent change1.43
Price - 52 week price percent change−4.61
Avg Trading Volume Last 3 months8.76
Price - 5 Day % Change1.42
Price % Change Month To Date−5.03
Relative (S&P500) price percent change - 04 week−6.29
52 week High Date22 Jul 2026
Price - 26 week price percent change9.78
PDATE23 Sep 2026
Price - YTD price percent change−8.88
Relative (S&P500) price percent change - 52 week4.66
NPRICE640.95
Relative (S&P500) price percent change - 26 week10.43
52 week Low537.30
52 week High795.00
Beta1.33
Relative (S&P500) price percent change - Year to Date3.77

Dividends & Corporate Events

Payouts to shareholders, splits and bonus issues, and company meetings — newest first.

Dividend per share₹ per share, by fiscal year
₹5.00
₹5.00
  • Dividend yield0.78%
  • Payout ratio28.66%
  • 5-year average dividend₹5.00 a share
  • Latest dividend₹2.50 per share · 24 Jul 2026

Corporate calendar

  • MeetingAnnual General Meeting
  • Dividend₹2.50 per share · 250% · Final dividend
  • BoardQuarterly Results
  • BoardAudited Results & Final Dividend
  • MeetingPostal Ballot
  • Dividend₹2.50 per share · 250% · Interim dividend
  • BoardQuarterly Results
  • BoardQuarterly Results
Show 14 older events
  • MeetingAnnual General Meeting
  • BoardQuarterly Results
  • Dividend₹2.50 per share · 250% · Final dividend
  • BoardAudited Results & Final Dividend
  • Dividend₹2.50 per share · 250% · Interim dividend
  • BoardQuarterly Results & Interim Dividend
  • MeetingPostal Ballot
  • BoardQuarterly Results
  • MeetingAnnual General Meeting
  • Dividend₹2.50 per share · 250% · Final dividend
  • MeetingPostal Ballot
  • Dividend₹2.50 per share · 250% · Interim dividend
  • Dividend₹2.50 per share · 250% · Final dividend
  • Dividend₹2.50 per share · 250% · Interim dividend

About Jubilant Ingrevia

Chemical Manufacturing

Jubilant Ingrevia Limited is a globally integrated life sciences and specialty chemicals company. Its segments include Specialty Chemicals, Nutrition & Health Solutions and Chemical Intermediates. The Specialty chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and Microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical intermediates segment includes Acetyls and Specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks, such as amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines and so on. This sub-segment includes insecticides, herbicides and fungicides. In nutrition and health ingredients, it offers products like Vitamin B3 & Picolinates (Chromium & Zinc) which are fully backward integrated.

Key people

  • Hari Shanker BhartiaExecutive Co-Chairman of the Board
  • Varun GuptaPresident, Chief Financial Officer
  • Deepak JainChief Executive Officer, Managing Director, Executive Director
  • Vijay Kumar SrivastavaChief of Operations, Whole-Time Director
  • Vinita KoulSenior Vice President, Head - Human Resources
  • Deepanjali GulatiCompliance Officer, Company Secretary

Company facts

  • NSE symbolJUBLINGREA
  • BSE code543271
  • ISININE0BY001018
  • IndustryChemical Manufacturing
  • IndexNIFTY 500
  • Market cap₹10,094 Cr
  • Revenue (FY26)₹4,388 Cr
  • Net profit (FY26)₹278 Cr

In the News

Recent headlines about Jubilant Ingrevia — they open on Mint in a new tab.

Stock data comes from the exchange feed via our data provider and may be delayed. It is for information only and is not a recommendation to buy or sell. See all stocks →

Frequently Asked Questions

Jubilant Ingrevia (NSE: JUBLINGREA) last traded at ₹634.85 on the NSE, down 0.71% (₹4.54) on the day, as of 24 Sep 2026, 8:53 AM. On the BSE it was ₹635.55. The day's range was ₹632.60 – ₹649.50.

Jubilant Ingrevia's 52-week high is ₹794.95 (22 Jul 2026) and its 52-week low is ₹535.30 (9 Mar 2026). At ₹634.85 the share is 20.1% below its high and 18.6% above its low.

Jubilant Ingrevia's market capitalisation is ₹10,094 Cr (₹10,094 Cr). It is part of the NIFTY 500 index.

Jubilant Ingrevia's P/E ratio (trailing 12 months) is 31.14. The sector average is 20.26, so investors pay 54% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹19.42.

Jubilant Ingrevia shares are down 4.61% over the last year, down 8.88% so far this year, up 9.78% over 6 months, up 1.43% over 3 months. Over the last year the stock did 4.66% better than the market.

In FY26 (year to Mar 2026), Jubilant Ingrevia reported revenue of ₹4,388 Cr (up 5.04% on the year before) and a net profit of ₹278 Cr. Earnings per share were ₹17.51.

Yes. Jubilant Ingrevia's latest dividend is ₹2.50 per share (250%, final dividend), with an ex-date of 24 Jul 2026. The dividend yield is 0.78%. It has paid 8 dividends in the records shown on this page.

Of 6 analysts covering Jubilant Ingrevia, 5 are bullish (4 strong buy, 1 buy), 1 say hold and 0 are bearish. The consensus is Strong Buy (average rating 1.50 on a scale where 1 is Strong Buy and 5 is Strong Sell). Analyst views are opinions, not a guarantee.

As of Jun 2026: Promoter 45.22%, FII 6.49%, MF 22.39%, Other 25.90%.

Jubilant Ingrevia's listed peers in Chemical Manufacturing include Asian Paints, Solar Industries India, Pidilite Industries, SRF, Linde India. By market capitalisation it ranks #6 of 6 in this group.